Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
927.15
-19.95 (-2.11%) Zydus Lifesciences - Quaterly Results
Date: 20-05-2025
The turnover is pegged at Rs. 58196.00 millions for the March 2025 quarter. The mentioned figure indicates a rise of about 74.64% as against Rs. 33324.00 millions during the year-ago period.The Net Profit of the company vaulted to 100.23% to Rs. 28137.00 millions from Rs. 14052.00 millions in the previous quarter.Operating profit for the quarter ended March 2025 rose to 39581.00 millions as compared to 19303.00 millions of corresponding quarter ended March 2024.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202503 | 202403 | % Var | 202503 | 202403 | % Var | 202503 | 202403 | % Var | |
| Sales | 58196.00 | 33324.00 | 74.64 | 151163.00 | 108187.00 | 39.72 | 151163.00 | 108187.00 | 39.72 |
| Other Income | 1854.00 | 3688.00 | -49.73 | 9058.00 | 11595.00 | -21.88 | 9058.00 | 11595.00 | -21.88 |
| PBIDT | 39581.00 | 19303.00 | 105.05 | 84325.00 | 51435.00 | 63.94 | 84325.00 | 51435.00 | 63.94 |
| Interest | 1554.00 | 1062.00 | 46.33 | 4639.00 | 3907.00 | 18.74 | 4639.00 | 3907.00 | 18.74 |
| PBDT | 38027.00 | 18155.00 | 109.46 | 79686.00 | 47442.00 | 67.97 | 79686.00 | 47442.00 | 67.97 |
| Depreciation | 1280.00 | 1306.00 | -1.99 | 5239.00 | 5044.00 | 3.87 | 5239.00 | 5044.00 | 3.87 |
| PBT | 36747.00 | 16849.00 | 118.10 | 74447.00 | 42398.00 | 75.59 | 74447.00 | 42398.00 | 75.59 |
| TAX | 8610.00 | 2797.00 | 207.83 | 16698.00 | 7983.00 | 109.17 | 16698.00 | 7983.00 | 109.17 |
| Deferred Tax | 345.00 | -1278.00 | -127.00 | 873.00 | -1360.00 | -164.19 | 873.00 | -1360.00 | -164.19 |
| PAT | 28137.00 | 14052.00 | 100.23 | 57749.00 | 34415.00 | 67.80 | 57749.00 | 34415.00 | 67.80 |
| Equity | 1006.00 | 1006.00 | 0.00 | 1006.00 | 1006.00 | 0.00 | 1006.00 | 1006.00 | 0.00 |
| PBIDTM(%) | 68.01 | 57.93 | 17.42 | 55.78 | 47.54 | 17.33 | 55.78 | 47.54 | 17.33 |